Illumina Ret. a saját tőke
Mi az Illumina Ret. a saját tőke?
A Ret. a saját tőke az Illumina, Inc. - -42.80%
Mi a Ret. a saját tőke meghatározása?
A saját tőke megtérülése egy vállalkozás nyereségességének mértéke a részvényes saját tőkéjének könyv szerinti értékéhez viszonyítva. Ezt úgy számítják ki, hogy a pénzügyi év nettó eredményét a teljes részvényes tőkével osztják el.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. a saját tőke a Miscellaneous szektor a LSE-on cégekben a Illumina -hoz képest
Mit csinál Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
ret. a saját tőke -hoz hasonló cégek Illumina
- Bossini International nak Ret. a saját tőke -42.92% van
- Bharat Road Network nak Ret. a saját tőke -42.90% van
- Arcus Biosciences Inc nak Ret. a saját tőke -42.86% van
- Monarch Mining nak Ret. a saját tőke -42.83% van
- Shandong Molong Petroleum Machinery nak Ret. a saját tőke -42.82% van
- Galiano Gold nak Ret. a saját tőke -42.81% van
- Illumina nak Ret. a saját tőke -42.80% van
- Hi-Level Technology nak Ret. a saját tőke -42.80% van
- Vimy Resources nak Ret. a saját tőke -42.78% van
- Vimy Resources nak Ret. a saját tőke -42.78% van
- Altan Rio Minerals nak Ret. a saját tőke -42.76% van
- U.S. Gold Corp nak Ret. a saját tőke -42.73% van
- E Automotive Inc nak Ret. a saját tőke -42.72% van